Biography
I have been working on liquid biopsy research for more than a decade now with support from the National Institute of Health. One of my research goals is to demonstrate the clinical significance of ctDNA in early-stage breast cancer treated with neoadjuvant therapy. I contribute my expertise to the PLUMB Study in order to advance our understanding of metastatic ILC and allow the development of lobular-specific disease assessment criteria.